Lacosamida Dr. Reddys (Lacosamide)

• Lacosamide is an antiepileptic drug used as adjunctive therapy for focal seizures.
• Focal (partial‑onset) seizures: Reduces seizure frequency when added to existing antiepileptic regimens.
• Epilepsy with focal onset: Improves overall seizure control in patients not fully managed by monotherapy.
• Adjunctive therapy for epilepsy: Provides additional seizure reduction when combined with other approved agents.

• Lacosamide selectively enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyperexcitable neuronal membranes. By prolonging the inactivated state of these channels, it reduces repetitive neuronal firing that underlies focal seizure activity, without significantly affecting normal neuronal conduction.

Lacosamide may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

• Dizziness: Transient sensation of light‑headedness.
• Nausea: Mild to moderate stomach upset.
• Headache: Occasional tension‑type pain.
• Somnolence: Increased sleepiness.
• Blurred vision: Temporary visual disturbances.
• Fatigue: Generalized tiredness.

Serious or Rare Side Effects

• Cardiac arrhythmia (PR‑interval prolongation): May cause conduction abnormalities.
• Atrial fibrillation: Irregular heart rhythm episodes.
• Severe skin reactions (e.g., Stevens‑Johnson syndrome): Requires immediate medical attention.
• Suicidal ideation: New or worsening thoughts of self‑harm.
• Respiratory depression: Reduced breathing effort, especially with CNS depressants.
• Anaphylaxis: Acute allergic reaction with hives, swelling, or airway compromise.

• When using Lacosamide, consider the following safety measures.
• Renal impairment: Adjust monitoring as the drug is primarily excreted unchanged by the kidneys.
• Hepatic impairment: Use caution; liver dysfunction may affect drug metabolism.
• Cardiac conduction: Perform baseline and periodic ECGs to detect PR‑interval changes.
• Pregnancy: Safety not established; weigh potential benefits against risks.
• Concomitant CNS depressants: May increase sedation and respiratory depression.
• Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with several medications; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine): May exacerbate cardiac conduction effects.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): Can increase lacosamide plasma concentrations.
• Strong CYP3A4 inducers (e.g., carbamazepine): May reduce lacosamide efficacy.

Moderate Interactions (Monitor Closely)

• Other antiepileptics (e.g., phenytoin, valproate): May alter each other's plasma levels.
• CNS depressants (e.g., opioids, benzodiazepines): Potential for enhanced sedation.
• Alcohol: Can increase dizziness and coordination impairment.